2020 Pharmaceutical Crystallization Summit

2020 Pharmaceutical Crystallization Summit

Cranbury, N.J., June 26, 2020 – J-STAR Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients globally, today launched its 1st annual Pharmaceutical Crystallization Summit, organized by CfPC (Center …

Center for Pharma Crystallization at J-Star Research Annual Conference

Center for Pharma Crystallization at J-STAR Research Annual Conference

Crystallization technologies are bridges between drug substances and drug products enabling consistent safety and efficacy profiles of small molecule based medicines. To fully utilize existing tools and develop better new methodologies for solving bottleneck problems in new drug development, the …

J-Star Research Structural Elucidation and NMR Expansion

J-STAR Research Structural Elucidation and NMR Expansion

J-STAR Research has recently established significant impurity isolation and structural elucidation capabilities.  The R&D team is comprised of experts in identifying and characterizing low levels (e.g. 0.1%) of impurities in chemical intermediates and APIs.  This is done by impurity enrichment …

J-Star Logo

J-STAR Research, Inc launches new website

South Plainfield, NJ., March 12, 2020 — J-STAR Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://www.jstar-research.com. The new site …

J-Star Logo

Porton and Xtalpi Announced Strategic Cooperation

March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the …

J-Star Logo

Porton Completes Acquisition of J-STAR Research

CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …

J-Star Logo

Porton Completes Acquisition of Porton USA

CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …

Scroll to Top